Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

NCT03766607 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Competing other studies

Conditions

Gastric Cancer

Interventions

DRUG: Trastuzumab
DRUG: Ramucirumab
DRUG: Paclitaxel

Sponsor

Korean South West Oncology Group